BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Endothelial cell
,
Neocentromeres
,
Rosiglitazone
,
rs4950928
,
GATA1
,
Apoptosis
,
Hepatitis
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
lipid modification
(biogroup)
NextBio Summary
General Info
Body Atlas
Most Correlated Tissues
Liver
Kidney cortex
Ileum mucosa
Colon mucosa
Myometrium
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Alpha-1-antitrypsin deficiency
Disorder of digestive system
Liver cancer
Listeriosis
Renal interstitial fibrosis
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
ARQ 197
tivozanib
CGP 60474
N-(4-bromo-2-fluorophenyl)-6-methoxy-7-((1-methylpiperidin-4-yl)methoxy)quinazolin-4-amine
KW 2449
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
PCDH11X
FUBP3
CAMK1
DIDO1
TLK2
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
L1000 CMAP - Embryonic stem HUES3 cells treated with small molecule perturbagens
L1000 CMAP - Prostate cancer PC3.101 cells with CRISPR-targeted gene knockouts
L1000 CMAP - Melanoma A375 cells with CRISPR-targeted gene knockouts
L1000 CMAP - Colorectal cancer HT29.311 cells with CRISPR-targeted gene knockouts
L1000 CMAP - Motor neuron MNEU.E cells treated with small molecule perturbagens
Explore Curated Studies Results
Literature
Most Relevant Literature
Lipid modification in Wnt structure and function.
Pharmacotherapies for lipid modification: beyond the statins.
Double-tailed lipid modification as a promising candidate for oligonucleotide delivery in mammalian …
Changes in HDL cholesterol and cardiovascular outcomes after lipid modification therapy.
Bacterial lipid modification enhances immunoprophylaxis of filarial abundant larval transcript-2 pro…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Effectiveness of Intensive Lipid Modification Medication in Preventing the Progression of Peripheral…
REVEAL: Randomized EValuation of the Effects of Anacetrapib Through Lipid-modification
Effect of EPA-DHA Supplement, Life Style Modification Standard Treatment on Clinical Outcome Lipid M…
Lifestyle Modification and Metformin Use in the Treatment of HIV
Century Trial, a Randomized Lifestyle Modification Study for Management of Stable Coronary Artery Di…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ